SEOM-TTCC clinical guideline in nasopharynx cancer (2021).
Clin Transl Oncol
; 24(4): 670-680, 2022 Apr.
Article
em En
| MEDLINE
| ID: mdl-35303267
ABSTRACT
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Nasofaríngeas
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
En
Revista:
Clin Transl Oncol
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Espanha